Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.
The European market for dental biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes. The level of development of the dental implant market within a given country highly dictates the corresponding size and growth of the DBGS market within that region. As the patient demand for dental implant procedures increases, the potential number of cases that require a bone grafting procedure also increases. This in turn generates demand for dental bone graft substitutes, barrier membranes and the dental growth factor product, Emdogain®.